Thymic carcinoma is a rare and aggressive form of cancer that develops in the thymus, a small organ located behind the breastbone. Unlike its less aggressive relative, thymoma, thymic carcinoma grows quickly and has a higher tendency to spread throughout the body, making it particularly challenging to treat.
Epidemiology
Thymic carcinoma is an extremely rare disease, affecting only a small number of people each year. In the United States, approximately 400 people are diagnosed annually with thymic epithelial tumors, which include both thymoma and thymic carcinoma. Of these cases, thymic carcinoma represents about one in every five diagnoses, making it significantly less common than thymoma.[1][2]
The disease most commonly affects adults between the ages of 40 and 75 years old. However, research examining cases from 2001 to 2015 in the United States found that the peak incidence occurs in people aged 70 to 74 years. Men appear to be diagnosed with thymic carcinoma more frequently than women. In the United States, people of Asian or Pacific Islander heritage have a higher rate of diagnosis compared to other ethnic groups.[1][5]
After thymoma, thymic carcinoma is the second most common type of cancer affecting the thymus gland. Despite being the most frequent tumor found in the thymus, these cancers remain rare overall, representing only about 0.2% to 1.5% of all malignancies. The rarity of thymic carcinoma makes it difficult to study and understand fully, which is why most treatment guidelines are based on expert opinions and small studies rather than large-scale research.[5][14]
Causes
The exact causes of thymic carcinoma remain largely unknown. Scientists have not identified specific factors that directly cause the disease to develop. This makes thymic carcinoma different from many other cancers where clear risk factors such as smoking or sun exposure have been established.[1]
What researchers do know is that thymic carcinoma originates from epithelial cells, which are cells that cover the outside surface of the thymus. In thymic carcinoma, these cells undergo abnormal changes that cause them to look very different from normal thymus cells when examined under a microscope. Unlike thymoma, where the cancer cells still resemble normal thymus cells, thymic carcinoma cells are infiltrative and do not arrange themselves in the normal pattern seen in healthy thymus tissue.[2][5]
Research has shown that the genetic and molecular profile of thymic carcinoma differs from that of thymoma. Interestingly, thymic epithelial tumors have the lowest tumor mutational burden of all solid tumors in adults, meaning they have fewer genetic mutations than most other types of cancer. This unique characteristic may contribute to why certain treatments work differently for thymic cancers compared to other malignancies.[4][24]
Thymic carcinoma does not appear to be linked to family history, which means the risk is not inherited from parents. Additionally, no environmental factors or lifestyle choices have been identified that increase the risk of developing this disease. This lack of known preventable causes makes thymic carcinoma particularly challenging from a public health perspective.[1][20]
Risk Factors
Because thymic carcinoma is so rare, very few risk factors have been identified. The risk factors that are known are not under a person’s control, meaning there is currently no way to reduce the likelihood of developing this disease through lifestyle changes or preventive measures.[1]
Age is one of the most significant risk factors. While thymic carcinoma can occur in younger people, the risk increases substantially with age, particularly after age 40. The highest rates of diagnosis are seen in people in their seventies. This age-related pattern suggests that changes that accumulate over time may play a role in the development of the disease, though the exact mechanisms remain unclear.[1][5]
Ethnicity also appears to influence risk. People of Asian American or Pacific Islander heritage have been found to have higher rates of thymic carcinoma compared to other ethnic groups in the United States. The reasons for this disparity are not well understood and require further research to determine whether genetic factors, environmental exposures, or other elements contribute to this increased risk.[1]
Gender may play a role as well, with studies indicating that males are diagnosed with thymic carcinoma more frequently than females. This gender difference has been observed across multiple studies but the biological basis for this pattern has not been determined.[5]
It is important to note that having one or more of these risk factors does not mean a person will definitely develop thymic carcinoma. Many people with these characteristics never develop the disease, and some people without any known risk factors are still diagnosed. The rarity of thymic carcinoma means that even among higher-risk groups, the actual likelihood of developing this cancer remains very low.[20]
Symptoms
One of the most challenging aspects of thymic carcinoma is that early-stage disease typically causes no symptoms at all. Many patients do not experience any signs that something is wrong until the cancer has grown large enough to affect nearby structures in the chest. This absence of early warning signs often means that thymic carcinoma is discovered at a more advanced stage, when treatment becomes more complex.[2][3]
When symptoms do appear, they are usually related to the tumor pressing on or invading nearby organs and blood vessels in the chest. The most common symptoms include a persistent cough that does not go away or gets worse over time. This cough may be dry or produce mucus, and it differs from the temporary cough associated with a common cold because it continues for weeks or months without improvement.[2][10]
Chest pain or a feeling of pressure on the chest is another frequent symptom. Patients may describe this as a heaviness or tightness that does not go away. Shortness of breath can occur when the tumor grows large enough to compress the airways or lungs, making it harder to take deep breaths. Some people notice these breathing difficulties particularly when lying down or during physical activity.[1][13]
Trouble swallowing, known medically as dysphagia, can develop if the tumor presses against the esophagus, the tube that carries food from the mouth to the stomach. This may initially feel like food is getting stuck or going down slowly, and it can progress to difficulty swallowing liquids as well. A hoarse voice may occur if the tumor affects nerves that control the vocal cords.[2][10]
Unlike thymoma, thymic carcinoma is rarely associated with paraneoplastic syndromes, which are conditions that occur when the immune system attacks healthy tissues in addition to cancer cells. The most common paraneoplastic syndrome linked to thymoma is myasthenia gravis, a condition causing muscle weakness, but this is uncommon in thymic carcinoma patients. This difference helps doctors distinguish between the two types of thymic tumors.[5][7]
Some patients experience general symptoms such as unexplained weight loss, loss of appetite, and persistent tiredness or fatigue. These systemic symptoms may indicate that the disease has spread beyond the thymus to other parts of the body, such as the bones or liver, which thymic carcinoma is more likely to do compared to thymoma.[5][7]
Prevention
Unfortunately, there is currently no known way to prevent thymic carcinoma. Because the causes of the disease remain unclear and no modifiable risk factors have been identified, medical experts cannot recommend specific lifestyle changes, dietary modifications, or other preventive measures that would reduce the risk of developing this cancer.[1][20]
The lack of identifiable environmental or behavioral risk factors means that unlike some other cancers where prevention strategies exist—such as avoiding tobacco to reduce lung cancer risk or using sunscreen to prevent skin cancer—thymic carcinoma offers no such opportunities for risk reduction. This can be frustrating for individuals concerned about their health, but it reflects the current state of medical knowledge about this rare disease.[1]
No screening tests are recommended for thymic carcinoma in the general population. Screening tests are medical examinations performed on people without symptoms to detect disease early, when it is most treatable. Examples include mammograms for breast cancer or colonoscopies for colon cancer. However, because thymic carcinoma is so rare and affects such a small portion of the population, routine screening would not be practical or cost-effective. Most cases are discovered incidentally when a chest X-ray or CT scan is performed for another reason.[1][20]
The absence of prevention strategies means that early detection relies on recognizing symptoms promptly and seeking medical evaluation. If you experience persistent chest symptoms such as a cough that will not go away, chest pain, shortness of breath, or difficulty swallowing, it is important to see a healthcare provider for evaluation. While these symptoms are much more commonly caused by other, less serious conditions, prompt medical attention ensures that any serious illness, including thymic carcinoma, can be identified and treated as early as possible.[2]
Pathophysiology
Understanding what happens in the body when thymic carcinoma develops requires first understanding the thymus itself. The thymus is a small organ located in the upper chest, behind the breastbone and above the heart. It is part of the lymphatic system, which plays a crucial role in the body’s immune defenses. The primary job of the thymus is to produce and train special white blood cells called T-lymphocytes or T-cells, which help protect the body against infections by identifying and destroying viruses, bacteria, and other harmful invaders.[2][10]
The thymus consists of two main types of cells: epithelial cells and lymphocytes. Epithelial cells form the structural framework of the thymus, while lymphocytes are the immune cells that develop within this framework. Both thymoma and thymic carcinoma arise from the epithelial cells, which is why they are collectively called thymic epithelial tumors or TETs.[1][2]
In thymic carcinoma, the epithelial cells undergo abnormal changes that cause them to look very different from normal thymus cells when examined under a microscope. These cancer cells lose the organized, lobular pattern typical of healthy thymus tissue and instead become infiltrative, meaning they aggressively invade surrounding tissues. This is a key difference from thymoma, where cancer cells still closely resemble normal thymus cells and maintain a more organized structure.[5][6]
Thymic carcinoma cells behave aggressively in several ways. They grow and divide much more rapidly than thymoma cells, allowing the tumor to increase in size relatively quickly. More importantly, they have a significantly higher tendency to spread beyond the thymus to other parts of the body, a process called metastasis. Common sites of spread include the lining of the lungs (pleura), the lungs themselves, the liver, and bones. This ability to metastasize is what makes thymic carcinoma much more difficult to treat and associated with poorer outcomes compared to thymoma.[2][5]
As a thymic carcinoma tumor grows within the chest, it can compress or invade nearby structures. The tumor may press against the trachea (windpipe) or bronchi (airways leading to the lungs), causing breathing difficulties. It can push against the esophagus, making swallowing difficult. Invasion of nerves can lead to symptoms like hoarseness if the nerves controlling the vocal cords are affected. When the tumor compresses major blood vessels, particularly the superior vena cava—the large vein that returns blood from the upper body to the heart—it can cause severe swelling in the face, neck, and arms.[1][7]
Unlike thymoma, thymic carcinoma is rarely associated with defects in T-cell selection that lead to autoimmune conditions. In thymoma, the tumor environment can interfere with the normal process by which the thymus eliminates self-reactive T-cells, leading to conditions like myasthenia gravis where the immune system attacks the body’s own tissues. This process involves decreased expression of a gene called AIRE (autoimmune regulator). Thymic carcinoma generally does not cause these immune system abnormalities, which helps doctors distinguish between the two types of tumors.[24]
At the molecular level, thymic carcinoma has distinct characteristics. Research has shown that it has different genetic and molecular features compared to thymoma, though specific immunohistochemical markers unique to thymic carcinoma have not yet been identified. Interestingly, thymic epithelial tumors overall have the lowest tumor mutational burden among all adult solid tumors, meaning they accumulate fewer genetic mutations than most other cancers. This unique feature may influence how these tumors respond to different types of treatment, particularly newer therapies that target specific genetic changes.[4][5]
The World Health Organization classifies thymic tumors based on their appearance under the microscope. Thymomas are categorized as types A, AB, B1, B2, and B3, with differences based on the proportion of lymphocytes present and how the epithelial cells look. Thymic carcinoma is sometimes referred to as type C thymoma in the older classification system, but it represents a distinctly different entity with more aggressive behavior and worse prognosis.[5][7]
When thymic carcinoma spreads to other parts of the body, it can disrupt the normal function of those organs. Metastases to the liver can interfere with the liver’s ability to filter toxins and produce essential proteins. Spread to the bones can cause pain and increase the risk of fractures. Pleural metastases—cancer spread to the lining of the lungs—can cause fluid accumulation around the lungs, leading to breathing difficulties. At the time of diagnosis, spread outside the chest cavity occurs in less than 7% of cases, but the risk increases as the disease progresses.[5][6]
